Flow-induced pressure differentially regulates endothelin-1, urotensin II, adrenomedullin, and relaxin in pulmonary vascular endothelium.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Biochemical and Biophysical Research Communications - BBRC

• Publication date

  2001-11-23

• Fields of study

  Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1006/BBRC.2001.5946PMID 11708807
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of shear stress on86Rb+ efflux from calf pulmonary artery endothelial cells

  2006cited by this paper
• The pregnancy hormone relaxin is a player in human heart failure

  2001cited by this paper
• Potent vasodilator responses to human urotensin-II in human pulmonary and abdominal resistance arteries.

  2001cited by this paper
• Pulmonary Release and Coronary and Peripheral Consumption of Big Endothelin and Endothelin-1 in Severe Heart Failure: Acute Effects of Vasodilator Therapy

  2000cited by this paper
• Regulation of cardiac adrenomedullin-mRNA in different stages of experimental heart failure.

  1999cited by this paper
• Adrenomedullin and the control of fluid and electrolyte homeostasis.

  1999cited by this paper
• Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14

  1999cited by this paper
• Endothelin-1 gene suppression by shear stress: pharmacological evaluation of the role of tyrosine kinase, intracellular calcium, cytoskeleton, and mechanosensitive channels.

  1999cited by this paper
• Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord.

  1998cited by this paper
• Endothelin-1 and endothelin-converting enzyme-1 gene regulation by shear stress and flow-induced pressure.

  1998cited by this paper
• Short-term oral endothelin-receptor antagonist therapy in conventionally treated patients with symptomatic severe chronic heart failure.

  1998cited by this paper
• Increased cardiac expression of endothelin-1 mRNA in ischemic heart failure in rats.

  1997cited by this paper
• Mechanical and neuroendocrine regulation of the endocrine heart.

  1996cited by this paper
• Pulmonary hypertension caused by congestive heart failure is ameliorated by long-term application of an endothelin receptor antagonist. Increased expression of endothelin-1 messenger ribonucleic acid and endothelin-1-like immunoreactivity in the lung in congestive heart failure in rats.

  1996cited by this paper
• Flow-Dependent Regulation of Vascular Function

  1995cited by this paper
• Shear Stress in the Circulation

  1995cited by this paper
• Elevation of circulating and ventricular adrenomedullin in human congestive heart failure.

  1995cited by this paper
• Pressure enhances endothelin-1 release from cultured human endothelial cells.

  1995cited by this paper
• Human relaxins: chemistry and biology.

  1994cited by this paper
• Plasma Endothelin Correlates With the Extent of Pulmonary Hypertension in Patients With Chronic Congestive Heart Failure

  1992cited by this paper
• Increased endothelin in experimental heart failure.

  1990cited by this paper
• A novel potent vasoconstrictor peptide produced by vascular endothelial cells

  1988cited by this paper
• Shear stress induced stimulation of mammalian cell metabolism

  1988cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• Effects of fluid flow on living vascular cells.

  1984cited by this paper
• A Simple Sequentially Rejective Multiple Test Procedure

  1979cited by this paper
• Boundary Layer Theory

  1955cited by this paper

• The proteomic fingerprint in infants with single ventricle heart disease in the interstage period: evidence of chronic inflammation and widespread activation of biological networks

  2023cites this paper
• Relaxin-2 as a Potential Biomarker in Cardiovascular Diseases

  2022cites this paper
• Transcriptional evaluation of relaxin and endothelin-1 axis in heart failure patients: First evidence of its involvement during left ventricular assist device support.

  2020cites this paper
• Relaxin-2 for heart failure with preserved ejection fraction (HFpEF): Rationale for future clinical trials.

  2019cites this paper
• Effects of human relaxin-2 (serelaxin) on hypoxic pulmonary vasoconstriction during acute hypoxia in a sheep model

  2018cites this paper
• The actions of relaxin on the human cardiovascular system

  2017cites this paper
• Redox Mechanisms Influencing cGMP Signaling in Pulmonary Vascular Physiology and Pathophysiology.

  2017cites this paper
• Pulmonary arterial compliance and pulmonary hemodynamic effects of Serelaxin in a sheep model

  2017cites this paper
• Pulmonary Hypertension in the Potential Kidney Transplant Recipient

  2017cites this paper
• Structural commonality of C1q TNF‐related proteins and their potential to activate relaxin/insulin‐like family peptide receptor 1 signalling pathways in cancer cells

  2017cites this paper
• Relaxin serum levels in acute heart failure are associated with pulmonary hypertension and right heart overload

  2017cites this paper
• The Assembly and Application of 'Shear Rings': A Novel Endothelial Model for Orbital, Unidirectional and Periodic Fluid Flow and Shear Stress.

  2016cites this paper
• Relaxin for the Treatment of Acute Decompensated Heart Failure: Pharmacology, Mechanisms of Action, and Clinical Evidence

  2016cites this paper
• Guidelines and Consensus: Statement on Pregnancy in Pulmonary Hypertension from the Pulmonary Vascular Research Institute

  2016cites this paper
• International Union of Basic and Clinical Pharmacology. XCV. Recent Advances in the Understanding of the Pharmacology and Biological Roles of Relaxin Family Peptide Receptors 1–4, the Receptors for Relaxin Family Peptides

  2015influential citation
• Statement on Pregnancy in Pulmonary Hypertension from the Pulmonary Vascular Research Institute

  2015cites this paper
• Pulmonary Arterial Hypertension and Oxidative Stress

  2014cites this paper
• Recombinant Human Relaxin-2: (How) Can a Pregnancy Hormone Save Lives in Acute Heart Failure?

  2014cites this paper
• Reactive oxygen species in pulmonary vascular remodeling.

  2013cites this paper
• Yet to Come Reactive Oxygen Species in Pulmonary Vascular Remodeling Comprehensive Physiology Inflammation Shear stress Hypoxia Contractile phenotypic markers Proliferative phenotypic markers Altered Ca 2 + homeostasis Vascular SMC SMC contraction and proliferation Growth factors Pulmonary vascular

  2013cites this paper
• Relaxin levels in pulmonary hypertension: a comparison between pulmonary arterial hypertension and diastolic heart failure-induced pulmonary hypertension.

  2012cites this paper
• Pulmonary Hypertension in Hemodialysis Patients

  2012cites this paper
• Unexplained pulmonary hypertension in peritoneal dialysis and hemodialysis patients.

  2012cites this paper
• Relaxin inhibits early steps in vascular inflammation.

  2011cites this paper
• Endothelin‐1 gene regulation

  2011cites this paper
• Role of urotensin II in health and disease.

  2010cites this paper
• Relaxin: A New Approach for the Treatment of Acute Congestive Heart Failure

  2010cites this paper
• Role of Novel Biomarkers in Chronic Kidney Disease: Urotensin II

  2010cites this paper
• Cadherin 5 and Annexin V as Circulating Endothelial Microparticles: Markers for Atherosclerotic Vascular Lesions in Patients with Chronic Renal Failure

  2010cites this paper
• Involvement of Novel Cardiac Peptides in Healthy and Ischemic Hearts

  2009cites this paper
• Pulmonary Endothelial Control of the Pulmonary Microcirculation

  2009cites this paper
• Therapeutic targets in hypertension: is there a place for antagonists of the most potent vasoconstrictors?

  2008cites this paper
• Urotensin II in cardiovascular regulation

  2008cites this paper
• Relaxin, a pleiotropic vasodilator for the treatment of heart failure

  2008cites this paper
• Different Gene Expression Patterns in the Lungs of Patients with Secondary Pulmonary Hypertension

  2008cites this paper
• Increased plasma urotensin-II levels are associated with diabetic retinopathy and carotid atherosclerosis in Type 2 diabetes.

  2008cites this paper
• Urotensin II: a cardiovascular and renal update

  2008cites this paper
• Urotensin-II in the lung: A matter for vascular remodelling and pulmonary hypertension?

  2007cites this paper
• Atrasentan Treatment of Pulmonary Vascular Disease in Piglets With Increased Pulmonary Blood Flow

  2007cites this paper
• Pulmonary vascular changes in piglets with increased pulmonary blood flow and pressure

  2007cites this paper
• Pulmonary Hypertension in Hemodialysis Patients: An Unrecognized Threat

  2006cites this paper
• Human Urotensin II as a Link between Hypertension and Coronary Artery Disease

  2006cites this paper
• 'Relaxin' the stiffened heart and arteries: the therapeutic potential for relaxin in the treatment of cardiovascular disease.

  2006cites this paper
• Relaxin-a pleiotropic hormone and its emerging role for experimental and clinical therapeutics.

  2006cites this paper
• Urotensin II and biomarkers of endothelial activation and atherosclerosis in end-stage renal disease.

  2006cites this paper
• Urotensin II in end-stage renal disease: an inverse correlate of sympathetic function and cardiac natriuretic peptides.

  2005cites this paper
• Endothelin-1 in Congenital Heart Disease

  2005cites this paper
• Receptors for Relaxin Family Peptides

  2005cites this paper
• Pressure-Induced Inflammatory Signaling in Lung Endothelial Cells

  2005cites this paper
• [Pathophysiological reactions of the pulmonary circulation in airway and lung diseases].

  2005cites this paper
• Emerging roles of urotensin-II in cardiovascular disease.

  2004cites this paper
• Relaxin: new functions for an old peptide.

  2004cites this paper
• Emerging role of relaxin in renal and cardiovascular function.

  2004cites this paper
• The pathogenesis of pulmonary hypertension in haemodialysis patients via arterio-venous access.

  2004cites this paper
• Pulmonary blood pressure, not flow, is associated with net endothelin-1 production in the lungs of patients with congenital heart disease and normal pulmonary vascular resistance.

  2003cites this paper
• Role of endothelin in the pathogenesis of acute laminitis in horses

  2003cites this paper
• Relaxin: a pregnancy hormone as central player of body fluid and circulation homeostasis

  2003cites this paper
• Interaction between endogenous nitric oxide and carbon monoxide in the pathogenesis of hypoxic pulmonary hypertension

  2003cites this paper
• Physiological or pathological--a role for relaxin in the cardiovascular system?

  2003cites this paper
• Is urotensin‐II the new endothelin?

  2002cites this paper
• Molecular and cellular basis of pulmonary vascular remodeling in pulmonary hypertension.

  2002cites this paper
• Effect of Relaxin in Two Models of Renal Mass Reduction

  2002cites this paper
• Pulmonary blood pressure, not flow, is associated with net endothelin-1 production in the lungs of patients with congenital heart disease and normal pulmonary vascular resistance

  year unknowncites this paper